Skip to main content
Erschienen in: Heart and Vessels 6/2014

01.11.2014 | Original Article

The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue

verfasst von: Piotr Sobanski, Malgorzata Krajnik, Mohammed Shaqura, Elzbieta Bloch-Boguslawska, Michael Schäfer, Shaaban A. Mousa

Erschienen in: Heart and Vessels | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Functional evidence suggests that the stimulation of peripheral and central opioid receptors (ORs) is able to modulate heart function. Moreover, selective stimulation of either cardiac or central ORs evokes preconditioning and, therefore, protects the heart against ischemic injury. However, anatomic evidence for OR subtypes in the human heart is scarce. Human heart tissue obtained during autopsy after sudden death was examined immunohistochemically for mu- (MOR), kappa- (KOR), and delta- (DOR) OR subtypes. MOR and DOR immunoreactivity was found mainly in myocardial cells, as well as on sparse individual nerve fibers. KOR immunoreactivity was identified predominantly in myocardial cells and on intrinsic cardiac adrenergic (ICA) cell-like structures. Double immunofluorescence confocal microscopy revealed that DOR colocalized with the neuronal marker PGP9.5, as well as with the sensory neuron marker calcitonin gene-related peptide (CGRP). CGRP-immunoreactive (IR) fibers were detected either in nerve bundles or as sparse individual fibers containing varicose-like structures. Our findings offer the first hint of an anatomic basis for the existence of OR subtypes in the human heart by demonstrating their presence in CGRP-IR sensory nerve fibers, small cells with an eccentric nucleus resembling ICA cells, and myocardial cells. Taken together, this suggests the role of opioids in both the neural transmission and regulation of myocardial cell function.
Literatur
1.
Zurück zum Zitat Verma-Gandhu M, Verdu EF, Bercik P, Blennerhassett PA, Al-Mutawaly N, Ghia JE, Collins SM (2007) Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut 56:358–364PubMedCentralPubMedCrossRef Verma-Gandhu M, Verdu EF, Bercik P, Blennerhassett PA, Al-Mutawaly N, Ghia JE, Collins SM (2007) Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut 56:358–364PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Krajnik M, Podolec Z, Siekierka M, Sykutera M, Pufal E, Sobanski P, Makarewicz R, Neef C, Punt N, Zylicz Z (2009) Morphine inhalation by cancer patients: a comparison of different nebulization techniques using pharmacokinetic, spirometric, and gasometric parameters. J Pain Symp Manag 38:747–757CrossRef Krajnik M, Podolec Z, Siekierka M, Sykutera M, Pufal E, Sobanski P, Makarewicz R, Neef C, Punt N, Zylicz Z (2009) Morphine inhalation by cancer patients: a comparison of different nebulization techniques using pharmacokinetic, spirometric, and gasometric parameters. J Pain Symp Manag 38:747–757CrossRef
3.
Zurück zum Zitat Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, Baird JC (2009) Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 33:771–777PubMedCrossRef Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, Baird JC (2009) Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 33:771–777PubMedCrossRef
4.
Zurück zum Zitat Barry U, Zuo Z (2005) Opioids: old drugs for potential new applications. Curr Pharm Des 11:1343–1350PubMedCrossRef Barry U, Zuo Z (2005) Opioids: old drugs for potential new applications. Curr Pharm Des 11:1343–1350PubMedCrossRef
5.
Zurück zum Zitat Wong GT, Ling Ling J, Irwin MG (2010) Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury. Anesth Analg 111:24–28PubMedCrossRef Wong GT, Ling Ling J, Irwin MG (2010) Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury. Anesth Analg 111:24–28PubMedCrossRef
6.
Zurück zum Zitat Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J (2008) Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294:H1444–H1451PubMedCrossRef Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J (2008) Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294:H1444–H1451PubMedCrossRef
7.
8.
Zurück zum Zitat Peart JN, Gross GJ (2004) Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype. Circulation 109:1219–1222PubMedCrossRef Peart JN, Gross GJ (2004) Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype. Circulation 109:1219–1222PubMedCrossRef
9.
Zurück zum Zitat Liang BT, Gross GJ (1999) Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 84:1396–1400PubMedCrossRef Liang BT, Gross GJ (1999) Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 84:1396–1400PubMedCrossRef
10.
Zurück zum Zitat Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, Redington AN (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 117:191–200CrossRef Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, Redington AN (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 117:191–200CrossRef
11.
Zurück zum Zitat Bolte C, Newman G, Schultz Jel J (2009) Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation. Am J Physiol Heart Circ Physiol 296:H967–H975PubMedCentralPubMedCrossRef Bolte C, Newman G, Schultz Jel J (2009) Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation. Am J Physiol Heart Circ Physiol 296:H967–H975PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Bolte C, Newman G, Schultz Jel J (2009) Kappa and delta opioid receptor signaling is augmented in the failing heart. J Mol Cell Cardiol 47:493–503PubMedCentralPubMedCrossRef Bolte C, Newman G, Schultz Jel J (2009) Kappa and delta opioid receptor signaling is augmented in the failing heart. J Mol Cell Cardiol 47:493–503PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Laurent S, Marsh JD, Smith TW (1985) Enkephalins have a direct positive inotropic effect on cultured cardiac myocytes. Proc Natl Acad Sci 82:5930–5934PubMedCentralPubMedCrossRef Laurent S, Marsh JD, Smith TW (1985) Enkephalins have a direct positive inotropic effect on cultured cardiac myocytes. Proc Natl Acad Sci 82:5930–5934PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Balasubramanian S, Ramakrishnan S, Charboneau R, Wang J, Barke R, Roy S (2001) Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol 33:2179–2187PubMedCrossRef Balasubramanian S, Ramakrishnan S, Charboneau R, Wang J, Barke R, Roy S (2001) Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol 33:2179–2187PubMedCrossRef
15.
Zurück zum Zitat Zhao S-H, Gao H-Q, Ji X, Wang Y, Liu X-J, You B-A, Cui X-P, Qiu J (2013) Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy. Heart Vessels 28:101–113PubMedCrossRef Zhao S-H, Gao H-Q, Ji X, Wang Y, Liu X-J, You B-A, Cui X-P, Qiu J (2013) Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy. Heart Vessels 28:101–113PubMedCrossRef
16.
Zurück zum Zitat Mousa SA, Shaqura M, Schaper J, Treskatsch S, Habazettl H, Schafer M, Abdul-Khaliq H (2011) Developmental expression of delta-opioid receptors during maturation of the parasympathetic, sympathetic, and sensory innervations of the neonatal heart: early targets for opioid regulation of autonomic control. J Comp Neurol 519:957–971PubMedCrossRef Mousa SA, Shaqura M, Schaper J, Treskatsch S, Habazettl H, Schafer M, Abdul-Khaliq H (2011) Developmental expression of delta-opioid receptors during maturation of the parasympathetic, sympathetic, and sensory innervations of the neonatal heart: early targets for opioid regulation of autonomic control. J Comp Neurol 519:957–971PubMedCrossRef
17.
Zurück zum Zitat Mousa SA, Shaqura M, Schaper J, Huang W, Treskatsch S, Habazettl H, Abdul-Khaliq H, Schafer M (2010) Identification of mu- and kappa-opioid receptors as potential targets to regulate parasympathetic, sympathetic, and sensory neurons within rat intracardiac ganglia. J Comp Neurol 518:3836–3847PubMedCrossRef Mousa SA, Shaqura M, Schaper J, Huang W, Treskatsch S, Habazettl H, Abdul-Khaliq H, Schafer M (2010) Identification of mu- and kappa-opioid receptors as potential targets to regulate parasympathetic, sympathetic, and sensory neurons within rat intracardiac ganglia. J Comp Neurol 518:3836–3847PubMedCrossRef
18.
Zurück zum Zitat Bell SP, Sack MN, Patel A, Opie LH, Yellon DM (2000) Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 36:2296–2302PubMedCrossRef Bell SP, Sack MN, Patel A, Opie LH, Yellon DM (2000) Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 36:2296–2302PubMedCrossRef
19.
Zurück zum Zitat Mcdonald J, Leonard AD, Serrano-Gomez A, Young SP, Swanevelder J, Thompson JP, Lambert DG (2010) Assessment of nociceptin/orphanin FQ and μ-opioid receptor mRNA in the human right atrium. Br J Anaesth 104:698–704PubMedCrossRef Mcdonald J, Leonard AD, Serrano-Gomez A, Young SP, Swanevelder J, Thompson JP, Lambert DG (2010) Assessment of nociceptin/orphanin FQ and μ-opioid receptor mRNA in the human right atrium. Br J Anaesth 104:698–704PubMedCrossRef
20.
Zurück zum Zitat Peng J, Sarkar S, Chang SL (2012) Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend 124:223–228PubMedCentralPubMedCrossRef Peng J, Sarkar S, Chang SL (2012) Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend 124:223–228PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Mousa SA, Straub RH, Schafer M, Stein C (2007) Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 66:871–879PubMedCentralPubMedCrossRef Mousa SA, Straub RH, Schafer M, Stein C (2007) Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 66:871–879PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, Schafer M (2007) Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain: J Neurol 130:502–513CrossRef Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, Schafer M (2007) Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain: J Neurol 130:502–513CrossRef
23.
Zurück zum Zitat Riedl MS, Schnell SA, Overland AC, Chabot-Dore AJ, Taylor AM, Ribeiro-Da-Silva A, Elde RP, Wilcox GL, Stone LS (2009) Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn. J Comp Neurol 513:385–398PubMedCentralPubMedCrossRef Riedl MS, Schnell SA, Overland AC, Chabot-Dore AJ, Taylor AM, Ribeiro-Da-Silva A, Elde RP, Wilcox GL, Stone LS (2009) Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn. J Comp Neurol 513:385–398PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, Pintar JE (1999) Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24:243–252PubMedCrossRef Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, Pintar JE (1999) Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24:243–252PubMedCrossRef
25.
Zurück zum Zitat Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, Elde R (1995) Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328–3341PubMed Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, Elde R (1995) Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328–3341PubMed
26.
Zurück zum Zitat Arvidsson U, Dado RJ, Riedl M, Lee JH, Law PY, Loh HH, Elde R, Wessendorf MW (1995) delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15:1215–1235PubMed Arvidsson U, Dado RJ, Riedl M, Lee JH, Law PY, Loh HH, Elde R, Wessendorf MW (1995) delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15:1215–1235PubMed
27.
Zurück zum Zitat Schulz S, Schreff M, Koch T, Zimprich A, Gramsch C, Elde R, Hollt V (1998) Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience 82:613–622PubMedCrossRef Schulz S, Schreff M, Koch T, Zimprich A, Gramsch C, Elde R, Hollt V (1998) Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience 82:613–622PubMedCrossRef
28.
Zurück zum Zitat Brack A, Rittner HL, Machelska H, Shaqura M, Mousa SA, Labuz D, Zollner C, Schafer M, Stein C (2004) Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108:67–75PubMedCrossRef Brack A, Rittner HL, Machelska H, Shaqura M, Mousa SA, Labuz D, Zollner C, Schafer M, Stein C (2004) Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108:67–75PubMedCrossRef
29.
Zurück zum Zitat Krajnik M, Schafer M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Mousa SA (2010) Local pulmonary opioid network in patients with lung cancer: a putative modulator of respiratory function. Pharmacol Rep 62:139–149PubMedCrossRef Krajnik M, Schafer M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Mousa SA (2010) Local pulmonary opioid network in patients with lung cancer: a putative modulator of respiratory function. Pharmacol Rep 62:139–149PubMedCrossRef
30.
Zurück zum Zitat Mousa SA, Krajnik M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Schafer M (2010) Dynorphin expression, processing and receptors in the alveolar macrophages, cancer cells and bronchial epithelium of lung cancer patients. Histol Histopathol 25:755–764PubMed Mousa SA, Krajnik M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Schafer M (2010) Dynorphin expression, processing and receptors in the alveolar macrophages, cancer cells and bronchial epithelium of lung cancer patients. Histol Histopathol 25:755–764PubMed
31.
Zurück zum Zitat Franco-Cereceda A, Lundberg JM, Hokfelt T (1986) Somatostatin: an inhibitory parasympathetic transmitter in the human heart? Eur J Pharmacol 132:101–102PubMedCrossRef Franco-Cereceda A, Lundberg JM, Hokfelt T (1986) Somatostatin: an inhibitory parasympathetic transmitter in the human heart? Eur J Pharmacol 132:101–102PubMedCrossRef
32.
Zurück zum Zitat Wharton J, Polak JM, Gordon L, Banner NR, Springall DR, Rose M, Khagani A, Wallwork J, Yacoub MH (1990) Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res 66:900–912PubMedCrossRef Wharton J, Polak JM, Gordon L, Banner NR, Springall DR, Rose M, Khagani A, Wallwork J, Yacoub MH (1990) Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res 66:900–912PubMedCrossRef
33.
34.
Zurück zum Zitat Gordon L, Polak JM, Moscoso GJ, Smith A, Kuhn DM, Wharton J (1993) Development of the peptidergic innervation of human heart. J Anat 183(Pt 1):131–140PubMedCentralPubMed Gordon L, Polak JM, Moscoso GJ, Smith A, Kuhn DM, Wharton J (1993) Development of the peptidergic innervation of human heart. J Anat 183(Pt 1):131–140PubMedCentralPubMed
35.
Zurück zum Zitat Adams DJ, Cuevas J (2004) Electrophysiological properties of intrinsic cardiac neurons. In: Armour JA, Ardell JL (eds) Basic and clinical neurocardiology. Oxford University Press, New York, pp 1–60 Adams DJ, Cuevas J (2004) Electrophysiological properties of intrinsic cardiac neurons. In: Armour JA, Ardell JL (eds) Basic and clinical neurocardiology. Oxford University Press, New York, pp 1–60
36.
Zurück zum Zitat Lendeckel U, Muller C, Rocken C, Laube B, Tager M, Huth C, Klein HU, Goette A (2005) Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol 28(Suppl 1):S275–S279PubMedCrossRef Lendeckel U, Muller C, Rocken C, Laube B, Tager M, Huth C, Klein HU, Goette A (2005) Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol 28(Suppl 1):S275–S279PubMedCrossRef
37.
Zurück zum Zitat Huang MH, Wang HQ, Roeske WR, Birnbaum Y, Wu Y, Yang NP, Lin Y, Ye Y, Mcadoo DJ, Hughes MG, Lick SD, Boor PJ, Lui CY, Uretsky BF (2007) Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. Am J Physiol Heart Circ Physiol 293:H376–H384PubMedCrossRef Huang MH, Wang HQ, Roeske WR, Birnbaum Y, Wu Y, Yang NP, Lin Y, Ye Y, Mcadoo DJ, Hughes MG, Lick SD, Boor PJ, Lui CY, Uretsky BF (2007) Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. Am J Physiol Heart Circ Physiol 293:H376–H384PubMedCrossRef
38.
Zurück zum Zitat Huang MH, Nguyen V, Wu Y, Rastogi S, Lui CY, Birnbaum Y, Wang HQ, Ware DL, Chauhan M, Garg N, Poh KK, Ye L, Omar AR, Tan HC, Uretsky BF, Fujise K (2009) Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovasc Res 84:452–460PubMedCrossRef Huang MH, Nguyen V, Wu Y, Rastogi S, Lui CY, Birnbaum Y, Wang HQ, Ware DL, Chauhan M, Garg N, Poh KK, Ye L, Omar AR, Tan HC, Uretsky BF, Fujise K (2009) Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovasc Res 84:452–460PubMedCrossRef
39.
Zurück zum Zitat Villemagne PS, Dannals RF, Ravert HT, Frost JJ (2002) PET imaging of human cardiac opioid receptors. Eur J Nucl Med Mol Imaging 29:1385–1388PubMedCrossRef Villemagne PS, Dannals RF, Ravert HT, Frost JJ (2002) PET imaging of human cardiac opioid receptors. Eur J Nucl Med Mol Imaging 29:1385–1388PubMedCrossRef
40.
Zurück zum Zitat Gross GJ (2003) Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 35:709–718PubMedCrossRef Gross GJ (2003) Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 35:709–718PubMedCrossRef
41.
42.
Zurück zum Zitat Takasaki Y, Wolff RA, Chien GL, Van Winkle DM (1999) Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta-opioid receptors. Am J Physiol 277:H2442–H2450PubMed Takasaki Y, Wolff RA, Chien GL, Van Winkle DM (1999) Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta-opioid receptors. Am J Physiol 277:H2442–H2450PubMed
43.
Zurück zum Zitat Lonergan T, Goodchild AK, Christie MJ, Pilowsky PM (2003) Presynaptic delta opioid receptors differentially modulate rhythm and pattern generation in the ventral respiratory group of the rat. Neuroscience 121:959–973PubMedCrossRef Lonergan T, Goodchild AK, Christie MJ, Pilowsky PM (2003) Presynaptic delta opioid receptors differentially modulate rhythm and pattern generation in the ventral respiratory group of the rat. Neuroscience 121:959–973PubMedCrossRef
44.
Zurück zum Zitat Zhao M, Wang HX, Yang J, Su YH, Su RJ, Wong TM (2008) delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway. Clin Exp Pharmacol Physiol 35:97–102PubMedCrossRef Zhao M, Wang HX, Yang J, Su YH, Su RJ, Wong TM (2008) delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway. Clin Exp Pharmacol Physiol 35:97–102PubMedCrossRef
45.
Zurück zum Zitat Yao LL, Wang YG, Cai WJ, Yao T, Zhu YC (2007) Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci 120:895–907PubMedCrossRef Yao LL, Wang YG, Cai WJ, Yao T, Zhu YC (2007) Survivin mediates the anti-apoptotic effect of delta-opioid receptor stimulation in cardiomyocytes. J Cell Sci 120:895–907PubMedCrossRef
46.
Zurück zum Zitat Coles JA Jr, Sigg DC, Iaizzo PA (2003) Role of kappa-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol 284:H2091–H2099PubMed Coles JA Jr, Sigg DC, Iaizzo PA (2003) Role of kappa-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol 284:H2091–H2099PubMed
47.
Zurück zum Zitat Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, Opie LH (2000) Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol 95:1–10 (discussion 11)PubMedCrossRef Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, Opie LH (2000) Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol 95:1–10 (discussion 11)PubMedCrossRef
48.
Zurück zum Zitat Cao Z, Liu L, Van Winkle DM (2003) Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol 285:H1032–H1039PubMed Cao Z, Liu L, Van Winkle DM (2003) Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol 285:H1032–H1039PubMed
49.
Zurück zum Zitat Wang GY, Wu S, Pei JM, Yu XC, Wong TM (2001) Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 280:H384–H391PubMed Wang GY, Wu S, Pei JM, Yu XC, Wong TM (2001) Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 280:H384–H391PubMed
50.
Zurück zum Zitat Wong TM, Lee AY, Tai KK (1990) Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart—an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22:1167–1175PubMedCrossRef Wong TM, Lee AY, Tai KK (1990) Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart—an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22:1167–1175PubMedCrossRef
51.
Zurück zum Zitat Starke K, Schoffel E, Illes P (1985) The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid kappa- but not mu- or delta-receptors. Naunyn Schmiedebergs Arch Pharmacol 329:206–209PubMedCrossRef Starke K, Schoffel E, Illes P (1985) The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid kappa- but not mu- or delta-receptors. Naunyn Schmiedebergs Arch Pharmacol 329:206–209PubMedCrossRef
52.
Zurück zum Zitat Schultz JE-J, Hsu AK, Nagase H, Gross GJ (1998) TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 274:H909–H914 Schultz JE-J, Hsu AK, Nagase H, Gross GJ (1998) TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 274:H909–H914
53.
Zurück zum Zitat Wu S, Li HY, Wong TM (1999) Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 84:1388–1395PubMedCrossRef Wu S, Li HY, Wong TM (1999) Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 84:1388–1395PubMedCrossRef
54.
Zurück zum Zitat Rechardt L, Aalto-Setala K, Purjeranta M, Pelto-Huikko M, Kyosola K (1986) Peptidergic innervation of human atrial myocardium: an electron microscopical and immunocytochemical study. J Auton Nerv Syst 17:21–32PubMedCrossRef Rechardt L, Aalto-Setala K, Purjeranta M, Pelto-Huikko M, Kyosola K (1986) Peptidergic innervation of human atrial myocardium: an electron microscopical and immunocytochemical study. J Auton Nerv Syst 17:21–32PubMedCrossRef
55.
Zurück zum Zitat Kyosola K, Aalto-Setala K, Harjula A, Mattila S, Rechardt L (1986) Substance P- and leu-enkephalin-immunoreactive nerves before and after myocardial ischaemia, hypothermic chemical cardioplegia and reperfusion injury during open-heart surgery. Scand J Thorac Cardiovasc Surg 20:89–92PubMedCrossRef Kyosola K, Aalto-Setala K, Harjula A, Mattila S, Rechardt L (1986) Substance P- and leu-enkephalin-immunoreactive nerves before and after myocardial ischaemia, hypothermic chemical cardioplegia and reperfusion injury during open-heart surgery. Scand J Thorac Cardiovasc Surg 20:89–92PubMedCrossRef
56.
Zurück zum Zitat Ventura C, Pintus G, Tadolini B (1998) Opioid peptide gene expression in the myocardial cell. Trends Cardiovasc Med 8:102–110PubMedCrossRef Ventura C, Pintus G, Tadolini B (1998) Opioid peptide gene expression in the myocardial cell. Trends Cardiovasc Med 8:102–110PubMedCrossRef
57.
Zurück zum Zitat Wilson SP, Klein RL, Chang KJ, Gasparis MS, Viveros OH, Yang WH (1980) Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves? Nature 288:707–709PubMedCrossRef Wilson SP, Klein RL, Chang KJ, Gasparis MS, Viveros OH, Yang WH (1980) Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves? Nature 288:707–709PubMedCrossRef
58.
Zurück zum Zitat Younes A, Pepe S, Yoshishige D, Caffrey JL, Lakatta EG (2005) Ischemic preconditioning increases the bioavailability of cardiac enkephalins. Am J Physiol Heart Circ Physiol 289:H1652–H1661PubMedCrossRef Younes A, Pepe S, Yoshishige D, Caffrey JL, Lakatta EG (2005) Ischemic preconditioning increases the bioavailability of cardiac enkephalins. Am J Physiol Heart Circ Physiol 289:H1652–H1661PubMedCrossRef
59.
Zurück zum Zitat Younes A, Pepe S, Barron BA, Spurgeon HA, Lakatta EG, Caffrey JL (2000) Cardiac synthesis, processing, and coronary release of enkephalin-related peptides. Am J Physiol Heart Circ Physiol 279:H1989–H1998PubMed Younes A, Pepe S, Barron BA, Spurgeon HA, Lakatta EG, Caffrey JL (2000) Cardiac synthesis, processing, and coronary release of enkephalin-related peptides. Am J Physiol Heart Circ Physiol 279:H1989–H1998PubMed
Metadaten
Titel
The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue
verfasst von
Piotr Sobanski
Malgorzata Krajnik
Mohammed Shaqura
Elzbieta Bloch-Boguslawska
Michael Schäfer
Shaaban A. Mousa
Publikationsdatum
01.11.2014
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 6/2014
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-013-0456-5

Weitere Artikel der Ausgabe 6/2014

Heart and Vessels 6/2014 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.